Human mesenchymal stem cells prolong survival and ameliorate motor deficit through trophic support in Huntington's disease mouse models.
about
Genetic Engineering of Mesenchymal Stem Cells to Induce Their Migration and SurvivalNeural and mesenchymal stem cells in animal models of Huntington's disease: past experiences and future challengesMesenchymal stem/stromal cells as a delivery platform in cell and gene therapiesDeveloping stem cell therapies for juvenile and adult-onset Huntington's diseaseMesenchymal stem cells for the treatment of neurodegenerative and psychiatric disordersMouse models of polyglutamine diseases in therapeutic approaches: review and data table. Part II.Dynamic Imaging of Marrow-Resident Granulocytes Interacting with Human Mesenchymal Stem Cells upon Systemic Lipopolysaccharide Challenge.Preclinical efficacy and mechanisms of mesenchymal stem cells in animal models of autoimmune diseases.The stem cell secretome and its role in brain repair.Use of Genetically Altered Stem Cells for the Treatment of Huntington's Disease.Transplantation of induced pluripotent stem cells improves functional recovery in Huntington's disease rat model.Implantation of undifferentiated and pre-differentiated human neural stem cells in the R6/2 transgenic mouse model of Huntington's diseaseIntrastriatal transplantation of neurotrophic factor-secreting human mesenchymal stem cells improves motor function and extends survival in R6/2 transgenic mouse model for Huntington's disease.Stem cell therapy in neurodegenerative diseases: From principles to practice.Bone Marrow-Derived Mesenchymal Stem Cells Repair Necrotic Pancreatic Tissue and Promote Angiogenesis by Secreting Cellular Growth Factors Involved in the SDF-1 α /CXCR4 Axis in RatsDisruption of the nuclear membrane by perinuclear inclusions of mutant huntingtin causes cell-cycle re-entry and striatal cell death in mouse and cell models of Huntington's disease.Testing stem cell therapy in a rat model of inflammatory bowel disease: role of bone marrow stem cells and stem cell factor in mucosal regenerationReductions in behavioral deficits and neuropathology in the R6/2 mouse model of Huntington's disease following transplantation of bone-marrow-derived mesenchymal stem cells is dependent on passage number.Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's diseaseAllogeneic guinea pig mesenchymal stem cells ameliorate neurological changes in experimental colitis.Mesenchymal stem cell-based therapy.Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice.Do mesenchymal stem cells function across species barriers? Relevance for xenotransplantation.Stem cell-based therapy for Huntington's disease.Concise review: adult mesenchymal stem cells, adult neural crest stem cells, and therapy of neurological pathologies: a state of play.Mesenchymal Stem Cells Stabilize Axonal Transports for Autophagic Clearance of α-Synuclein in Parkinsonian Models.Umbilical cord: an unlimited source of cells differentiable towards dopaminergic neuronsStem cell models of polyglutamine diseases and their use in cell-based therapies.Immunomodulation by mesenchymal stem cells: Interplay between mesenchymal stem cells and regulatory lymphocytes.Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety.Xenotransplantation of human adipose derived mesenchymal stem cells in a rodent model of Huntington's disease: motor and non-motor outcomes.Single-cell suspension methodology favors survival and vascularization of fetal striatal grafts in the YAC128 mouse model of Huntington's disease.Concise Review: The Use of Stem Cells for Understanding and Treating Huntington's Disease.Induced Pluripotent Stem Cell-Derived Neural Stem Cell Transplantations Reduced Behavioral Deficits and Ameliorated Neuropathological Changes in YAC128 Mouse Model of Huntington's Disease.Treatment of Spinocerebellar Ataxia With Mesenchymal Stem Cells: A Phase I/IIa Clinical Study.Functional role of mesenchymal stem cells in the treatment of chronic neurodegenerative diseases.Effects of Passage Number and Differentiation Protocol on the Generation of Dopaminergic Neurons from Rat Bone Marrow-Derived Mesenchymal Stem Cells.Defined serum- and xeno-free cryopreservation of mesenchymal stem cellsBone Marrow Derived Mesenchymal Stem Cells in Addiction Related Hippocampal Damages
P2860
Q26744561-B03B44AA-93A0-40B6-91DC-DA83528D1A0DQ26775932-4BB76EAA-34C8-49B6-A93F-538EAD669EFFQ26799107-68C61F29-3106-420B-8077-7EE26790FD04Q26799722-634AA2C0-CFAA-487A-A49B-FFFFCE65FAF8Q26801575-12E4265D-968C-4F81-A250-3C3BFDD9CC17Q27005950-C98EAE7F-7918-43A7-A332-424E5CF6F73EQ30538835-D8C8A66F-01E9-4887-9A50-FE6B7D4A026DQ33619017-37F5BA92-B53E-4AFB-8132-9767C3A1FC0CQ33771698-C6794FC9-B763-4B8D-8573-4C89FFE1AE68Q33788929-322145D3-C04E-4E5C-9659-37CDCE5ECA10Q33939904-DC2C597C-C5C4-4CB0-B8AF-C5134FFD23CDQ34372919-ADCBB306-6158-4DF1-BD92-13F57DE50985Q34406937-ED49C84D-C7C9-4B09-AA7E-64EB8F3CBF07Q34997944-7522E49B-0435-489C-A947-3883B59F169DQ35166316-98CE8855-153A-47F7-AC81-42A706C8A69BQ35239346-870B65BC-5202-4123-B76D-F1B482D6386EQ35326009-D49BFB14-DB42-4EA4-87DA-08E1A9F9127AQ35600187-706E6CFB-724A-49B4-BF49-2FA0080B4CDBQ35675598-60D36CD6-7FA5-4DBA-80B8-5F377385A81FQ36419634-FC5F8852-D85B-42AD-9CDA-B92A2CC66D91Q36546424-CC1FEF26-D3BA-4A50-BC34-F37BFA2E2AA9Q37050899-C9CB3C87-35A9-4366-A28C-9579DE5CC90AQ38043528-5934F017-2655-4F3D-B334-1EC142551387Q38055455-7F623CA2-08F2-444C-A0EE-3551355C0465Q38088965-67C8FF1F-101F-41F1-AC0B-A8CED72CAD4CQ38744332-1021D3C8-47C3-4095-ACB2-D7CC6FFEE2CDQ41429938-B7E754B7-CA41-4B0D-A1A2-C097B3783D20Q41472176-548A69F0-0A96-461E-A189-CC0922965A84Q42392488-D21C1D7D-B54A-4C2B-9BFF-E541993A4CC6Q42593149-481A7CFD-80D7-4685-9671-CB4D0AE6FA77Q42692081-368B525F-8F45-42D7-A586-0C2964B544A6Q45293677-B97ED690-D176-4C86-97A4-54D892343EBEQ45305684-9A64BA53-8F22-4F4C-8856-D3E1E5646471Q45305883-C85B70E2-FC40-474C-998F-F322DC3AED08Q45619589-76BC72BB-CA51-4187-B82D-D505C3F9D045Q47941437-D4C2DFAD-7081-440C-967B-980AC443C630Q54967971-26A70BC4-1156-40E3-BCA0-BD76C70805CDQ57094520-62DE6D99-85B4-4F3F-B369-4D8608DF03A3Q57146788-13D2FA4B-0FEE-4864-91F8-C316A6F31270
P2860
Human mesenchymal stem cells prolong survival and ameliorate motor deficit through trophic support in Huntington's disease mouse models.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Human mesenchymal stem cells p ...... ington's disease mouse models.
@ast
Human mesenchymal stem cells p ...... ington's disease mouse models.
@en
type
label
Human mesenchymal stem cells p ...... ington's disease mouse models.
@ast
Human mesenchymal stem cells p ...... ington's disease mouse models.
@en
prefLabel
Human mesenchymal stem cells p ...... ington's disease mouse models.
@ast
Human mesenchymal stem cells p ...... ington's disease mouse models.
@en
P2093
P2860
P1433
P1476
Human mesenchymal stem cells p ...... tington's disease mouse models
@en
P2093
Che-Kun James Shen
Hsin-Lan Wen
Hsiu Mei Hsieh-Li
Tzu-Hao Cheng
Ya-Chin Chang
Yuan-Ta Lin
P2860
P304
P356
10.1371/JOURNAL.PONE.0022924
P407
P577
2011-08-05T00:00:00Z